Ep. 94: Neffy Epinephrine Nasal Spray - Impact on Patients and Healthcare Providers
Part of the series: Allergy, Asthma & Immunology Innovations Podcast
This podcast was made in partnership with Allergy & Asthma Network.
We thank ARS Pharma for sponsoring this episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.
LISTEN TO EPISODE 94:
Managing anaphylaxis just became easier with Neffy, the FDA-approved nasal spray for epinephrine. This innovative, needle-free option is transforming emergency allergy care.
Dr. Autumn Burnette joins Dr. Payel Gupta and Kortney to discuss how Neffy works, who it’s best suited for, and its potential impact on anaphylaxis treatment. With her expertise in allergy and immunology, Dr. Burnette addresses common concerns about Neffy’s effectiveness, highlights its benefits, and shares practical details like cost, shelf life, and heat sensitivity.
What We Cover in Our Episode on Neffy Epinephrine Spray:
A Game-Changer for Anaphylaxis: Discover how Neffy offers a needle-free option for delivering life-saving epinephrine during severe allergic reactions.
Patient Benefits of Neffy: Learn how its ease of use and accessibility can make anaphylaxis management less daunting for patients.
Addressing Skepticism About Neffy: Dr. Burnette explains how studies validate Neffy’s effectiveness and addresses questions about trusting a nasal spray for emergencies.
Practical Tips for Neffy Use: Get insights on cost, insurance coverage, shelf life, and whether Neffy works with nasal congestion or nose jobs!
Expanding Treatment Options: Explore why having more options like Neffy is exciting for patients and healthcare providers alike.
About Our Expert on Neffy and Anaphylaxis Treatments
Dr. Autumn Burnette, MD, FACAAI, is a board-certified allergist and immunologist and an Assistant Professor at Howard University in Washington, DC. With expertise in hereditary angioedema, urticaria, asthma, and atopic dermatitis, Dr. Burnette brings a wealth of clinical knowledge and research experience to this episode. A sought-after speaker and advocate, she is committed to advancing allergy and immunology care through education, innovation, and patient-centered solution
More resources about anaphylaxis and epinephrine:
The Neffy!
Learn more about the technology and Neffy clinical trials in our other episode.
Timestamps
Our episode explores common patient questions about Neffy.
01:13 Dr. Autumn Burnette introduction
01:37 Patients’ interest in Neffy
02:26 Overview of Neffy
03:50 Key benefits of Neffy for patients
05:48 Addressing skepticism about nasal epinephrine
09:01 Potential concerns about overuse of Neffy
12:20 Trust in Neffy’s effectiveness
13:35 Identifying individuals for whom Neffy may not be suitable
15:08 Insurance coverage and cost considerations for Neffy
16:55 Prescription-only access to Neffy
18:33 Shelf life of Neffy
19:10 Heat sensitivity of Neffy
19:30 The significance of having more treatment options for anaphylaxis
